全球智库信息集成服务系统(G2TT): The FDA and ABCs: The Unintended Consequences of Antidepressant Warnings on Human Capital

G2TT

来源类型	Working Paper
规范类型	报告
DOI	10.3386/w17426
来源ID	Working Paper 17426
	The FDA and ABCs: The Unintended Consequences of Antidepressant Warnings on Human Capital
	Susan Busch; Ezra Golberstein; Ellen Meara
发表日期	2011-09-15
出版年	2011
语种	英语
摘要	Using annual cross-sectional data on over 100,000 adolescents aged 12-17, we studied academic and behavioral outcomes among those who were and were not likely affected by FDA warnings regarding the safety of antidepressants. Just before the FDA warnings, adolescents with probable depression had grade point averages 0.14 points higher than adolescents with depression just after the warnings. The FDA warnings also coincided with increased delinquency, use of tobacco and illicit drugs. Together, our results stress the importance of mental health and its treatment as an input into cognitive and non-cognitive aspects of human capital.
主题	Health, Education, and Welfare ; Health ; Labor Economics ; Demography and Aging ; Labor Supply and Demand
URL	https://www.nber.org/papers/w17426
来源智库	National Bureau of Economic Research (United States)
引用统计
资源类型	智库出版物
条目标识符	http://119.78.100.153/handle/2XGU8XDN/575100
推荐引用方式 GB/T 7714	Susan Busch,Ezra Golberstein,Ellen Meara. The FDA and ABCs: The Unintended Consequences of Antidepressant Warnings on Human Capital. 2011.